After clicking on a story, use the back arrow in your browser to return to your search results. Use phrases "in quotes" or the tools below to better filter your results.
Reata received FDA approval in February for Skyclarys, the first approved treatment for Friedreich’s ataxia, a disease that causes impaired walking and coordination in children.